Financial News
All
Basic Materials
Communication Services
Consumer Cyclical
Consumer Defensive
Energy
Financial Services
Healthcare
Industrials
Real Estate
Technology
Utilities
Macro
All Sentiment
Bullish
Neutral
Bearish
2,049 articles
📰
HYTN Appoints Fabian Monaco to Board of Directors
VANCOUVER, British Columbia, March 20, 2026 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE:HYTN, FSE: 85W0, OTC:HYTNF) ("HYTN" or the "Company"), a...
📰
HYTN Appoints Fabian Monaco to Board of Directors
VANCOUVER, British Columbia, March 20, 2026 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE:HYTN, FSE: 85W0, OTC:HYTNF) ("HYTN" or the "Company"), a...
📰
Does This $25 Million Bet on a Stock Down 61% Signal Turnaround Potential at $6?
Organon & Co. develops branded and biosimilar therapies with a focus on women’s health and specialty pharmaceuticals.
12 Consumer Discretionary Stocks Moving In Friday's After-Market Session
Gainers
Chegg (NYSE:CHGG) stock rose 21.7% to $0.55 during Friday's after-market session. The market value of their outstanding shares is at...
12 Health Care Stocks Moving In Friday's After-Market Session
Gainers
Firefly Neuroscience (NASDAQ:AIFF) stock rose 25.5% to $1.92 during Friday's after-market session. The company's market cap stands...
12 Health Care Stocks Moving In Friday's After-Market Session
Gainers
Firefly Neuroscience (NASDAQ:AIFF) stock rose 25.5% to $1.92 during Friday's after-market session. The company's market cap stands...
12 Health Care Stocks Moving In Friday's After-Market Session
Gainers
Firefly Neuroscience (NASDAQ:AIFF) stock rose 25.5% to $1.92 during Friday's after-market session. The company's market cap stands...
12 Health Care Stocks Moving In Friday's After-Market Session
Gainers
Firefly Neuroscience (NASDAQ:AIFF) stock rose 25.5% to $1.92 during Friday's after-market session. The company's market cap stands...
12 Health Care Stocks Moving In Friday's After-Market Session
Gainers
Firefly Neuroscience (NASDAQ:AIFF) stock rose 25.5% to $1.92 during Friday's after-market session. The company's market cap stands...
12 Health Care Stocks Moving In Friday's After-Market Session
Gainers
Firefly Neuroscience (NASDAQ:AIFF) stock rose 25.5% to $1.92 during Friday's after-market session. The company's market cap stands...
12 Health Care Stocks Moving In Friday's After-Market Session
Gainers
Firefly Neuroscience (NASDAQ:AIFF) stock rose 25.5% to $1.92 during Friday's after-market session. The company's market cap stands...
12 Health Care Stocks Moving In Friday's After-Market Session
Gainers
Firefly Neuroscience (NASDAQ:AIFF) stock rose 25.5% to $1.92 during Friday's after-market session. The company's market cap stands...
12 Health Care Stocks Moving In Friday's After-Market Session
Gainers
Firefly Neuroscience (NASDAQ:AIFF) stock rose 25.5% to $1.92 during Friday's after-market session. The company's market cap stands...
12 Health Care Stocks Moving In Friday's After-Market Session
Gainers
Firefly Neuroscience (NASDAQ:AIFF) stock rose 25.5% to $1.92 during Friday's after-market session. The company's market cap stands...
📰
This Specialized Heart Monitor Maker Just Caught the Eye of a Major Healthcare Fund
RTW Investments loads up on iRhythm Holdings with 1.18M Shares Worth $210 million. iRhythm delivers wearable cardiac monitoring and analytics...
LLY's Next-Gen Obesity Drug Meets Goal in First Phase III Study for T2D
Eli Lilly reports strong Phase III results for retatrutide in type 2 diabetes, with significant A1C reduction and up to 16.8% weight loss in the...
LLY's Next-Gen Obesity Drug Meets Goal in First Phase III Study for T2D
Eli Lilly reports strong Phase III results for retatrutide in type 2 diabetes, with significant A1C reduction and up to 16.8% weight loss in the...
LLY's Next-Gen Obesity Drug Meets Goal in First Phase III Study for T2D
Eli Lilly reports strong Phase III results for retatrutide in type 2 diabetes, with significant A1C reduction and up to 16.8% weight loss in the...
LLY's Next-Gen Obesity Drug Meets Goal in First Phase III Study for T2D
Eli Lilly reports strong Phase III results for retatrutide in type 2 diabetes, with significant A1C reduction and up to 16.8% weight loss in the...
Novartis Strikes $3B Oncology Deal for Breast Cancer Asset
NVS bets $2B upfront on SNV4818 to expand precision oncology in breast cancer, targeting a large mutation-driven market and boosting long-term...
Novartis Strikes $3B Oncology Deal for Breast Cancer Asset
NVS bets $2B upfront on SNV4818 to expand precision oncology in breast cancer, targeting a large mutation-driven market and boosting long-term...
Novartis Strikes $3B Oncology Deal for Breast Cancer Asset
NVS bets $2B upfront on SNV4818 to expand precision oncology in breast cancer, targeting a large mutation-driven market and boosting long-term...
Novartis Strikes $3B Oncology Deal for Breast Cancer Asset
NVS bets $2B upfront on SNV4818 to expand precision oncology in breast cancer, targeting a large mutation-driven market and boosting long-term...
Will the Recent Label Expansion of BMY's Sotyktu Boost Its Prospects?
BMY's Sotyktu PsA approval boosts its immunology push, expands market reach, and sharpens its competitive stance amid pressure from legacy drug...
Will the Recent Label Expansion of BMY's Sotyktu Boost Its Prospects?
BMY's Sotyktu PsA approval boosts its immunology push, expands market reach, and sharpens its competitive stance amid pressure from legacy drug...
Will the Recent Label Expansion of BMY's Sotyktu Boost Its Prospects?
BMY's Sotyktu PsA approval boosts its immunology push, expands market reach, and sharpens its competitive stance amid pressure from legacy drug...
Is Swarmer the Palantir of Drones? Investors Bet Big on Defense Tech Stock
Swarmer Inc.'s (NASDAQ:SWMR) explosive debut has investors asking whether this new AI-defense play could become the Palantir Technologies...
Deal Dispatch: Public Storage Buys National Storage For $10.5B, Mastercard Acquires BVNK, Domino's Franchisee Bankruptcy
New On The Block
Warburg Pincus is exploring a potential sale of Exeter Finance, a subprime auto lender, for an estimated price between $2.5 billion...
Bristol Myers Secures FDA Nod For Opdivo Plus Chemo For Untreated Hodgkin Lymphoma
The U.S. Food and Drug Administration (FDA) on Friday approved Bristol Myers Squibb & Co.’s (NYSE:BMY) Opdivo (nivolumab) with chemotherapy...
Planet Labs Has A Five Year Lead Over Its Nearest Competitor: Analyst
Planet Labs (NYSE:PL) surged on Friday after strong quarterly results and upbeat guidance reinforced confidence in its growth trajectory.
Analysts...
📰
This $91 Million Position Signals Conviction in a Biotech Stock Eyeing FDA Decision This Year
This clinical-stage biotech develops therapies for serious immunological diseases, with a focus on late-stage biologic candidates.
Why Are Shares Of Azitra Rising?
Shares of Azitra Inc (NASDAQ:AZTR) are trading higher Friday after the company announced private placement financing of up to $10.5 million, with the...
12 Health Care Stocks Moving In Friday's Intraday Session
Gainers
Azitra (AMEX:AZTR) stock rose 52.6% to $0.27 during Friday's regular session. The company's market cap stands at $1.8 million....
12 Health Care Stocks Moving In Friday's Intraday Session
Gainers
Azitra (AMEX:AZTR) stock rose 52.6% to $0.27 during Friday's regular session. The company's market cap stands at $1.8 million....
12 Health Care Stocks Moving In Friday's Intraday Session
Gainers
Azitra (AMEX:AZTR) stock rose 52.6% to $0.27 during Friday's regular session. The company's market cap stands at $1.8 million....
12 Health Care Stocks Moving In Friday's Intraday Session
Gainers
Azitra (AMEX:AZTR) stock rose 52.6% to $0.27 during Friday's regular session. The company's market cap stands at $1.8 million....
12 Health Care Stocks Moving In Friday's Intraday Session
Gainers
Azitra (AMEX:AZTR) stock rose 52.6% to $0.27 during Friday's regular session. The company's market cap stands at $1.8 million....
12 Health Care Stocks Moving In Friday's Intraday Session
Gainers
Azitra (AMEX:AZTR) stock rose 52.6% to $0.27 during Friday's regular session. The company's market cap stands at $1.8 million....
12 Health Care Stocks Moving In Friday's Intraday Session
Gainers
Azitra (AMEX:AZTR) stock rose 52.6% to $0.27 during Friday's regular session. The company's market cap stands at $1.8 million....
12 Health Care Stocks Moving In Friday's Intraday Session
Gainers
Azitra (AMEX:AZTR) stock rose 52.6% to $0.27 during Friday's regular session. The company's market cap stands at $1.8 million....
12 Health Care Stocks Moving In Friday's Intraday Session
Gainers
Azitra (AMEX:AZTR) stock rose 52.6% to $0.27 during Friday's regular session. The company's market cap stands at $1.8 million....
12 Health Care Stocks Moving In Friday's Intraday Session
Gainers
Azitra (AMEX:AZTR) stock rose 52.6% to $0.27 during Friday's regular session. The company's market cap stands at $1.8 million....
12 Health Care Stocks Moving In Friday's Intraday Session
Gainers
Azitra (AMEX:AZTR) stock rose 52.6% to $0.27 during Friday's regular session. The company's market cap stands at $1.8 million....
12 Health Care Stocks Moving In Friday's Intraday Session
Gainers
Azitra (AMEX:AZTR) stock rose 52.6% to $0.27 during Friday's regular session. The company's market cap stands at $1.8 million....
PANTHERx® Rare Selected by Rhythm Pharmaceuticals Inc. as the Exclusive U.S. Specialty Pharmacy for the Expanded Indication for IMCIVREE® (setmelanotide)
PITTSBURGH, March 20, 2026 /PRNewswire/ -- PANTHERx® Rare Pharmacy, the trusted leader and innovator in patient access and support services for...